Provided by Tiger Fintech (Singapore) Pte. Ltd.

Bio-Rad Laboratories

231.70
+4.792.11%
Volume:490.76K
Turnover:113.25M
Market Cap:6.31B
PE:-3.01
High:232.61
Open:228.23
Low:222.80
Close:226.91
Loading ...

Bio-Rad Q1 Gross Margin 52.3%

THOMSON REUTERS
·
02 May

Bio Rad Laboratories Inc - Expects FY25 Non-Gaap, Currency-Neutral REV to Range From About a 1.0 Percent Decline to 1.5 Percent Growth

THOMSON REUTERS
·
02 May

Bio-Rad Reports First-Quarter 2025 Financial Results

Business Wire
·
02 May

Bio-Rad Laboratories, Inc. (BIO): Among Billionaire Mason Hawkins’ Small-Cap Stocks with Huge Upside Potential

Insider Monkey
·
30 Apr

Bell Potter Keeps Their Buy Rating on Biome Australia Ltd (BIO)

TIPRANKS
·
29 Apr

BIO-key regains compliance with Nasdaq

TIPRANKS
·
25 Apr

BIO-key Regains Compliance with Nasdaq Listing Rules After Receiving Notice of Non-Compliance

GlobeNewswire
·
25 Apr

Analysts Estimate Bio-Rad Laboratories (BIO) to Report a Decline in Earnings: What to Look Out for

Zacks
·
24 Apr

Biodesix partner, Friends of Cancer Research, publishes data in Clinical Cancer Research, demonstrating strong association between ctDNA changes and treatment outcomes for patients with solid tumor types

GlobeNewswire
·
23 Apr

Does Bio-Rad Laboratories (BIO) Offer a Solid Financial Profile?

Insider Monkey
·
22 Apr

Should You be Optimistic on Bio-Rad Laboratories’s (BIO) Outlook?

Insider Monkey
·
21 Apr

Bio-Rad Laboratories Is Maintained at Equal-Weight by Wells Fargo

Dow Jones
·
18 Apr

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

THOMSON REUTERS
·
16 Apr

Bio-Rad to Report First Quarter 2025 Financial Results on Thursday, May 1, 2025

Business Wire
·
16 Apr

Arrowhead Pharmaceuticals Appoints Daniel Apel as Chief Financial Officer

Business Wire
·
16 Apr

BUZZ-Life sciences firms fall as China hikes tariff on US imports

Reuters
·
09 Apr

Bio Rad Laboratories Inc : RBC Cuts Target Price to $409 From $430

THOMSON REUTERS
·
08 Apr

KALA BIO Price Target Maintained With a $15.00/Share by HC Wainwright & Co.

Dow Jones
·
04 Apr

Further weakness as Bio-Rad Laboratories (NYSE:BIO) drops 5.0% this week, taking three-year losses to 61%

Simply Wall St.
·
04 Apr

Bio Protocol is introducing the protocol upgrade Bio V1, which includes a new Launchpad feature. BIO holders will have priority access to early project allocations.

Blockbeats
·
02 Apr